PortfoliosLab logo
Augmedix, Inc. (AUGX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US05105P1075

CUSIP

05105P107

IPO Date

Mar 31, 2021

Highlights

Market Cap

$116.16M

EPS (TTM)

-$0.47

Total Revenue (TTM)

$13.66M

Gross Profit (TTM)

$6.46M

EBITDA (TTM)

-$8.31M

Year Range

$0.73 - $2.62

Target Price

$2.92

Short %

4.02%

Short Ratio

5.73

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Augmedix, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Returns By Period


AUGX

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

-3.70%

1M

13.67%

6M

-5.18%

1Y

9.18%

5Y*

14.14%

10Y*

10.43%

*Annualized

Monthly Returns

The table below presents the monthly returns of AUGX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-24.44%-0.45%-7.05%-33.74%-66.12%-4.15%157.95%2.20%1.29%0.00%-59.83%
2023-1.28%5.19%7.41%72.99%22.92%30.00%-15.80%18.02%7.74%-14.56%20.00%10.80%275.00%
2022-18.41%-3.89%19.03%-2.04%-30.56%-10.00%-17.78%14.19%-14.20%2.07%-15.54%24.80%-50.48%
202110.00%9.09%-2.50%-15.90%-18.70%31.25%-28.57%-4.27%-12.26%-37.00%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AUGX is 22, meaning it’s performing worse than 78% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of AUGX is 2222
Overall Rank
The Sharpe Ratio Rank of AUGX is 2323
Sharpe Ratio Rank
The Sortino Ratio Rank of AUGX is 3030
Sortino Ratio Rank
The Omega Ratio Rank of AUGX is 3131
Omega Ratio Rank
The Calmar Ratio Rank of AUGX is 1010
Calmar Ratio Rank
The Martin Ratio Rank of AUGX is 1515
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Augmedix, Inc. (AUGX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Augmedix, Inc.. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Rolling 12-month Sharpe Ratio
AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Augmedix, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Augmedix, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Augmedix, Inc. was 90.00%, occurring on Jun 18, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90%Apr 8, 2021805Jun 18, 2024

Volatility

Volatility Chart

The current Augmedix, Inc. volatility is 1.47%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


AUGX (Augmedix, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Augmedix, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Augmedix, Inc., comparing actual results with analytics estimates. The company met analyst expectations for EPS in the past quarter.


-2.00-1.50-1.00-0.500.00AprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024April
-0.13
-0.13
Actual
Estimate

Valuation

The Valuation section provides an overview of how Augmedix, Inc. is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for AUGX relative to other companies in the Health Information Services industry. Currently, AUGX has a P/S ratio of 2.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for AUGX in comparison with other companies in the Health Information Services industry. Currently, AUGX has a P/B value of 11.1. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items